Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels
1 clinical trials · Condition
◉ Watch Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels
| Record | Firm | Date |
|---|---|---|
| Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations (NCT01131325) | Novartis Pharmaceuticals | 2010-10-21 |
Track Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels automatically
Every clearance here is in the API, with alerts when new ones post.